Oddo Mauro, Schmidt J Michael, Carrera Emmanuel, Badjatia Neeraj, Connolly E Sander, Presciutti Mary, Ostapkovich Noeleen D, Levine Joshua M, Le Roux Peter, Mayer Stephan A
Department of Neurology, Critical Care Division, Columbia University Medical Center, New York, NY, USA.
Crit Care Med. 2008 Dec;36(12):3233-8. doi: 10.1097/CCM.0b013e31818f4026.
To analyze the effect of tight glycemic control with the use of intensive insulin therapy on cerebral glucose metabolism in patients with severe brain injury.
Retrospective analysis of a prospective observational cohort.
University hospital neurologic intensive care unit.
Twenty patients (median age 59 yrs) monitored with cerebral microdialysis as part of their clinical care.
Intensive insulin therapy (systemic glucose target: 4.4-6.7 mmol/L [80-120 mg/dL]).
Brain tissue markers of glucose metabolism (cerebral microdialysis glucose and lactate/pyruvate ratio) and systemic glucose were collected hourly. Systemic glucose levels were categorized as within the target "tight" (4.4-6.7 mmol/L [80-120 mg/dL]) vs. "intermediate" (6.8-10.0 mmol/L [121-180 mg/dL]) range. Brain energy crisis was defined as a cerebral microdialysis glucose <0.7 mmol/L with a lactate/pyruvate ratio >40. We analyzed 2131 cerebral microdialysis samples: tight systemic glucose levels were associated with a greater prevalence of low cerebral microdialysis glucose (65% vs. 36%, p < 0.01) and brain energy crisis (25% vs.17%, p < 0.01) than intermediate levels. Using multivariable analysis, and adjusting for intracranial pressure and cerebral perfusion pressure, systemic glucose concentration (adjusted odds ratio 1.23, 95% confidence interval [CI] 1.10-1.37, for each 1 mmol/L decrease, p < 0.001) and insulin dose (adjusted odds ratio 1.10, 95% CI 1.04-1.17, for each 1 U/hr increase, p = 0.02) independently predicted brain energy crisis. Cerebral microdialysis glucose was lower in nonsurvivors than in survivors (0.46 +/- 0.23 vs. 1.04 +/- 0.56 mmol/L, p < 0.05). Brain energy crisis was associated with increased mortality at hospital discharge (adjusted odds ratio 7.36, 95% CI 1.37-39.51, p = 0.02).
In patients with severe brain injury, tight systemic glucose control is associated with reduced cerebral extracellular glucose availability and increased prevalence of brain energy crisis, which in turn correlates with increased mortality. Intensive insulin therapy may impair cerebral glucose metabolism after severe brain injury.
分析强化胰岛素治疗进行严格血糖控制对重型脑损伤患者脑葡萄糖代谢的影响。
对前瞻性观察队列进行回顾性分析。
大学医院神经重症监护病房。
20例患者(中位年龄59岁),作为临床护理的一部分接受脑微透析监测。
强化胰岛素治疗(全身血糖目标:4.4 - 6.7 mmol/L [80 - 120 mg/dL])。
每小时收集脑葡萄糖代谢的脑组织标志物(脑微透析葡萄糖及乳酸/丙酮酸比值)和全身血糖。全身血糖水平分为目标范围内的“严格”(4.4 - 6.7 mmol/L [80 - 120 mg/dL])与“中等”(6.8 - 10.0 mmol/L [121 - 180 mg/dL])范围。脑能量危机定义为脑微透析葡萄糖<0.7 mmol/L且乳酸/丙酮酸比值>40。我们分析了2131份脑微透析样本:与中等水平相比,严格的全身血糖水平与较低的脑微透析葡萄糖发生率(65%对36%,p < 0.01)和脑能量危机发生率(25%对17%,p < 0.01)相关。采用多变量分析,并对颅内压和脑灌注压进行校正后,全身血糖浓度(每降低1 mmol/L,校正比值比1.23,95%置信区间[CI] 1.10 - 1.37,p < 0.001)和胰岛素剂量(每增加1 U/hr,校正比值比1.10,95% CI 1.04 - 1.17,p = 0.02)独立预测脑能量危机。非存活者脑微透析葡萄糖低于存活者(0.4 ± 0.23对1.04 ± 0.56 mmol/L,p < 0.05)。脑能量危机与出院时死亡率增加相关(校正比值比7.36,95% CI 1.37 - 39.51,p = 0.02)。
在重型脑损伤患者中,严格的全身血糖控制与脑细胞外葡萄糖可用性降低及脑能量危机发生率增加相关,而这又与死亡率增加相关。强化胰岛素治疗可能损害重型脑损伤后的脑葡萄糖代谢。